Cefozopran may decrease the excretion rate of Abacavir which could result in a higher serum level. The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefozopran. The risk or severity of nephrotoxicity can be increased when Aceclofenac is combined with Cefozopran.

Cefozopran is a semisynthetic, broad-spectrum, fourth-generation cephalosporin with antibacterial activity. Cefozopran binds to and inactivates penicillin -binding proteins (PBPs) located on the inner membrane of the bacterial cell wall.

Cephalosporins have been well documented as potential causes of severe skin reactions. Cefozopran, a fourth generation cephalosporin, was reported to cause toxic epidermal necrolysis (TEN) in a 71-year-old woman with a history of psoriasis diagnosed with …

The potent therapeutic effect of cefozopran in those experimental infections in mice suggests that it would be effective against respiratory tract, urinary tract, and soft tissue infections caused by a variety of gram-positive and gram-negative bacteria in humans.

This substance record has relationships which can be visualized as a network with other substance records. A simplified representation of that network can be interactively explored …

Cefozopran is a commercial antibiotic that belongs to the class of 1,2,4-thiadiazole containing drugs, which have various biological activities. AI generated definition based on: Comprehensive Heterocyclic Chemistry IV, 2022

Cefozopran is a semisynthetic, broad-spectrum, fourth-generation cephalosporin with antibacterial activity. Cefozopran binds to and inactivates penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall.

A fourth-generation cephalosporin antibacterial agent with a broad spectrum of activity against Gram-positive and Gram-negative bacteria. Cefozopran has a 1-methyltetrazolethiol (MTT) moiety at C-3 of its cephalosporin core.

Chemical formula: C₁₉H₁₇N₉O₅S₂ Molecular mass: 515.079 g/mol PubChem compound: 9571080. This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows: Cefozopran is an active ingredient of these brands:

Cefozopran hydrochloride is a third-generation cephalosporin that was launched for the treatment of severe infections in immunocompromised patients caused by staphylococci and enterococci.